These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1711860)

  • 1. Report of a WHO workshop on synthetic peptides in HIV diagnosis and AIDS-related research, Moscow 24-26 May 1989. World Health Organization Global Programme on AIDS.
    AIDS; 1991 Jan; 5(1):WHO1-9. PubMed ID: 1711860
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
    Blish CA; Nguyen MA; Overbaugh J
    PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the diagnostic value of recombinant antigens and synthetic peptides that mimic the immunogenic epitopes of the envelop protein gp41 in the enzyme immunodetection of HIV-1 antibodies].
    Baranova EN; Puzyrev VF; Van'kova OE; Pimenov VK; Burkov AN; Obriadina AP; Ulanova TI
    Vopr Virusol; 2006; 51(3):46-8. PubMed ID: 16826757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.
    Barin F; Meyer L; Lancar R; Deveau C; Gharib M; Laporte A; Desenclos JC; Costagliola D
    J Clin Microbiol; 2005 Sep; 43(9):4441-7. PubMed ID: 16145089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for the use of synthetic antigens in immunodiagnosis.
    Khaitov RM; Andreev SM
    Biomed Sci; 1990; 1(6):553-64. PubMed ID: 1722715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody neutralization and escape by HIV-1.
    Wei X; Decker JM; Wang S; Hui H; Kappes JC; Wu X; Salazar-Gonzalez JF; Salazar MG; Kilby JM; Saag MS; Komarova NL; Nowak MA; Hahn BH; Kwong PD; Shaw GM
    Nature; 2003 Mar; 422(6929):307-12. PubMed ID: 12646921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
    Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
    Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
    Hernández M; Pozo L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a synthetic C34 trimer of HIV-1 gp41 as AIDS vaccines.
    Hashimoto C; Nomura W; Ohya A; Urano E; Miyauchi K; Narumi T; Aikawa H; Komano JA; Yamamoto N; Tamamura H
    Bioorg Med Chem; 2012 May; 20(10):3287-91. PubMed ID: 22507207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the fine structure of the antigenic determinants of the transmembrane protein in the HIV coat with chemically modified synthetic peptides.
    Andreev SM; Meshcheryakova DB; Vafina MG; Az'muko AA; Sidorova MV; Khaitov RM
    Biomed Sci; 1991; 2(3):271-8. PubMed ID: 1751760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe.
    Goudsmit J; Meloen RH; Brasseur R
    Intervirology; 1990; 31(6):327-38. PubMed ID: 1704000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.